ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Ms. Rosa - Cancer of the liver

Patient basic information Patient: Rosa Ms. (Rosa Anderson) Nationality: Congo (B) Diagnosis: bladder cancer Diagnostic hospital: HQ0 Treatment plan: Intervention treatment + medication treatment Household days: 25 days Treatment cost: about 1453341 yuan Treatment effect: Stability of the disease Description: Rosa Ms. from Congo (B) was diagnosed with bladder cancer locally.

Following the arrival of the patient, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's inspection reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process. After 25 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached hospital standards. Treatment results The patient's final condition stabilized.

When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to track recovery through the remote follow-up system. The patients commented: 'We are impressed by the level of expertise of Chinese doctors and the condition of the equipment at Chinese hospitals. 'Ladies and gentlemen, Ms.

Rosa experts have criticized this case as a typical case of cross-border suspiciousness in clinical cases. The multi-disciplinary collaborative mechanism for the development of interventions and drug therapies for bladder cancer reflects the comprehensive strength of Chinese hospitals in the field of suspiciousness diagnostics and a summary of how international medical services are regulated.

刚果(布),膀胱癌,中国医学科学院肿瘤医院,国际医疗,来华就医,中国医疗